Task: Answer the multiple-choice question.
Query: Which drug exhibits a 7.339\% human ether-à-go-go related gene (hERG) inhibition at 1uM?
Constraint: You must select none, one or more options from a or b without using any other words.
Options:
a.) CC(C)c1ccc(NC(=O)[C@H](Cc2c[nH]c3ccccc23)NC(=O)[C@@H]2Cc3ccccc3CN2)cc1
b.) COCC(C)n1c(SCC(=O)Nc2ccc3c(c2)OCCO3)nc2ccccc2c1=O
Answer: b. COCC(C)n1c(SCC(=O)Nc2ccc3c(c2)OCCO3)nc2ccccc2c1=O
{#Task|Problem statement!}: Answer the {#multiple choice|multiple-choice|MCQ!} question.
{#Question|Query!}: Which {#compound|drug!} {#has|exhibits!} a {herg_central_at_1uM#}{herg_central_at_1uM__units} {herg_central_at_1uM__names__noun}?
Constraint: You must select none, one or more options from {%multiple_choice_enum%2-5%aA1} without using any {#other|additional!} words.
Options:
{SMILES%herg_central_at_1uM%}
Answer: {%multiple_choice_result}. {SMILES#}
COCC(C)n1c(SCC(=O)Nc2ccc3c(c2)OCCO3)nc2ccccc2c1=O
COCC(C)n1c(SCC(=O)Nc2ccc3c(c2)OCCO3)nc2ccccc2c1=O
N-(2,3-dihydro-1,4-benzodioxin-6-yl)-2-[3-(1-methoxypropan-2-yl)-4-oxoquinazolin-2-yl]sulfanylacetamide